As a specialist in gastroenterology, internal medicine, and hepatology, I have used my medical expertise in many regards over the last two decades. As the founder & CEO of Progenabiome, a genetic sequencing research laboratory, I lead 35+ studies investigating the role of the gut flora in various diseases (see current list here).
I am also the CEO of Ventura Clinical Trials, where i have 20+ years experience leading clinical trials for cutting-edge research on various medical issues. Since March 2020, I have been at the forefront of COVID-19 research, leading ongoing FDA-approved clinical trials for treatment and prophylaxis (details here).
Through our study exploring the role of the gut flora in COVID-19, Progenabiome became the first lab worldwide to detect SARS-CoV-2 from Patient Fecal Samples by Whole Genome Sequencing. See data published in Gut Pathogens here.
With these findings and extensive knowledge on the Microbiome and disease, My partner and I at Topelia Therapeutics, Dr. Thomas Borody, developed what we feel is the best first line of defense against COVID-19, a combination of natural vitamins and meds: Biome Boosters , available at https://biomeboosters.com/. Proceeds support research via the Microbiome Research Foundation.
We also co-authored Let’s Talk Shit, a humorous, easy to digest explanation of gastrointestinal disorders, treatments, and next generation hope for gut-related diseases. Proceeds support research via the Microbiome Research Foundation. The book is available on Amazon and https://letstalkshit.org/.
As the first woman ever accepted into the University of Florida as a Clinical Gastroenterology Fellow, I believe i am a pioneer in the medical field. I have published articles in numerous prestigious medical journals, and am the Series Editor on the microbiome for Practical Gastroenterology, a peer review journal that reaches 18,000 gastroenterologists. I am also a speaker for the World Congress of Digestive Disease, MAGI, Microbiome Congress, International Drug Discovery Science and Technology Conference and NIST (National Institute of Standards and Technology).
Recent News: https://progenabiome.com/news
Publications: https://progenabiome.com/publications
Progenabiome: https://progenabiome.com/
Topelia Therapeutics: https://topeliatherapeutics.com/
Microbiome Research Foundation: https://microbiomeresearchfoundation.com/
Invited by: Leah Houston, MD
if the data has not been changed, no new rows will appear.
Day | Followers | Gain | % Gain |
---|---|---|---|
March 16, 2024 | 612 | -3 | -0.5% |
April 07, 2023 | 615 | +2 | +0.4% |
November 29, 2022 | 613 | +2 | +0.4% |
September 19, 2022 | 611 | +1 | +0.2% |
August 03, 2022 | 610 | +1 | +0.2% |
June 27, 2022 | 609 | +1 | +0.2% |
May 21, 2022 | 608 | +6 | +1.0% |
April 21, 2022 | 602 | +127 | +26.8% |
March 14, 2022 | 475 | +20 | +4.4% |
January 15, 2022 | 455 | +13 | +3.0% |